Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2026-09-23 16:05:36 ET · period of report 2026-09-21 · accession 0001622058-26-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-23 16:05 | 2026-09-21+ | MEDP | Troendle August J. | Pres, CEO, Dir, 10% | S - Sale | $626.62 | -70.9K | 433.4K | -14% | -$44.43M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-21 | S | D | 21,883 | $623.29 | 482,390 | D | — | — | (F1) The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $625.91. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2026-09-22 | S | D | 49,018 | $628.11 | 433,372 | D | — | — | (F1) The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $632.815. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |